Reports for ALLERGAN INC
Company Name
ALLERGAN INC
Totals |
||
Shortage reports |
87 |
|
| Actual shortage: | 2 (2%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (3%) | |
| Resolved: | 81 (93%) | |
Discontinuation Reports |
21 |
|
| To be discontinued: | 3 (14%) | |
| Discontinued: | 16 (76%) | |
| Reversed: | 2 (10%) | |
Late reports |
19 (18%) |
|
Overdue reports |
4 (67%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ASACOL | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2020-06-05 | 2020-07-30 | 116708 |
| ASACOL 800 | 800MG | TABLET (DELAYED-RELEASE) | Resolved | 2020-07-14 | 2021-01-28 | 120327 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2018-11-01 | 2019-02-16 | 65967 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2019-02-19 | 2019-05-22 | 76311 |
| BELKYRA | 10MG | SOLUTION | Resolved | 2021-07-05 | 2021-09-22 | 141860 |
| BETAGAN OPH SOLN 0.25% | 0.25% | LIQUID | Resolved | 2017-04-06 | 2017-08-04 | 5781 |
| BEZALIP SR | 400MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-11-19 | 2020-12-03 | 128643 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2019-10-24 | 2019-11-08 | 97094 |
| BLEPHAMIDE | 10% 0.2% | DROPS | Resolved | 2020-04-03 | 2020-04-07 | 110845 |
| BLEPHAMIDE | 10% 0.2% | DROPS | Resolved | 2021-04-13 | 2021-07-30 | 137389 |
| BLEPHAMIDE S.O.P. | 0.2% 10% | OINTMENT | Resolved | 2018-02-19 | 2019-11-08 | 40190 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2018-02-19 | 2018-04-21 | 40184 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2018-02-19 | 2018-04-21 | 40187 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2019-03-03 | 2019-04-15 | 77338 |
| BLEPHAMIDE | 0.2% 10% | DROPS | Resolved | 2019-03-03 | 2019-04-19 | 77342 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84750 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-27 | 163730 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2018-12-05 | 2019-02-08 | 68675 |
| BYSTOLIC | 5.0MG | TABLET | Resolved | 2019-05-25 | 2019-06-07 | 84758 |
| BYSTOLIC | 5MG | TABLET | Resolved | 2022-03-17 | 2022-06-30 | 156945 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ALOCRIL | 2% | LIQUID | Discontinued | 2018-11-28 | 2019-04-02 | 67803 |
| ALPHAGAN | 0.2% | LIQUID | To be discontinued | 2021-12-09 | 2021-12-09 | 150885 |
| ANDRODERM | 5MG | PATCH | Discontinued | 2021-11-26 | 2021-11-26 | 150081 |
| ANDRODERM | 2.5MG | PATCH | Discontinued | 2022-03-14 | 2022-03-14 | 156691 |
| ASACOL | 400MG | TABLET (ENTERIC-COATED) | Discontinued | 2020-07-31 | 2020-07-31 | 121616 |
| ASACOL 800 | 800MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-01-28 | 2021-01-28 | 132579 |
| BETAGAN 0.5% OPHTHALMIC SOL | 5MG | LIQUID | Discontinued | 2020-03-10 | 2020-03-10 | 108380 |
| BETAGAN OPH SOLN 0.25% | 0.25% | LIQUID | Discontinued | 2017-08-04 | 2017-08-04 | 18275 |
| BLEPHAMIDE | 0.2% 10% | DROPS | To be discontinued | 2021-12-02 | 2021-12-02 | 150359 |
| BLEPHAMIDE S.O.P. | 0.2% 10% | OINTMENT | Discontinued | 2019-07-31 | 2019-07-31 | 90343 |
| FIBRISTAL | 5MG | TABLET | Discontinued | 2020-10-06 | 2020-10-06 | 125735 |
| LOESTRIN 1.5/30 | 30MCG 1.5MG | TABLET | Discontinued | 2021-06-25 | 2021-06-26 | 141494 |
| MACROBID | 100MG | CAPSULE | Discontinued | 2021-06-16 | 2021-08-19 | 141050 |
| OPTICROM | 2% | SOLUTION | Discontinued | 2021-03-10 | 2021-03-10 | 135410 |
| PRED MILD | 0.12% | DROPS | Discontinued | 2021-12-09 | 2022-04-01 | 150889 |
| RAPAFLO | 4MG | CAPSULE | Discontinued | 2021-11-17 | 2021-11-17 | 149528 |
| RAPAFLO | 8MG | CAPSULE | To be discontinued | 2021-11-17 | 2022-03-15 | 149531 |
| TAZORAC | 0.05% | GEL | Discontinued | 2021-11-26 | 2021-11-27 | 149997 |
| TAZORAC | 0.1% | CREAM | Discontinued | 2021-11-26 | 2022-03-14 | 150061 |
| VIBERZI | 75MG | TABLET | Reversed | 2022-03-23 | 2022-06-29 | 157156 |